• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合理使用黏液促排药物治疗儿科气道疾病。

Rational use of mucoactive medications to treat pediatric airway disease.

机构信息

Pediatric Intensive Care Unit, Amsterdam UMC, Emma Children's Hospital, Location AMC, Amsterdam, the Netherlands.

Pediatric Pulmonary Medicine, Children's Hospital of Richmond, Virginia Commonwealth University, United States.

出版信息

Paediatr Respir Rev. 2020 Nov;36:8-14. doi: 10.1016/j.prrv.2020.06.007. Epub 2020 Jun 16.

DOI:10.1016/j.prrv.2020.06.007
PMID:32653467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7297155/
Abstract

Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are employed to treat these diseases with varying degrees of success. This manuscript reviews evidence for the use of these medications and future directions of study.

摘要

许多儿童气道疾病,特别是细支气管炎、囊性纤维化(CF)、非 CF 支气管扩张症(包括原发性纤毛运动障碍)、肺炎和严重哮喘,与气道分泌物潴留有关。为了治疗这些疾病,人们使用了能改善分泌物清除的药物,即黏液促排药物,这些药物在一定程度上取得了成功。本文综述了这些药物的使用证据和未来的研究方向。

相似文献

1
Rational use of mucoactive medications to treat pediatric airway disease.合理使用黏液促排药物治疗儿科气道疾病。
Paediatr Respir Rev. 2020 Nov;36:8-14. doi: 10.1016/j.prrv.2020.06.007. Epub 2020 Jun 16.
2
Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.用于慢性非囊性纤维化肺病的黏液活性药物:一项系统评价和荟萃分析。
Respirology. 2017 Aug;22(6):1084-1092. doi: 10.1111/resp.13047. Epub 2017 Apr 11.
3
Dornase alfa for cystic fibrosis.用于囊性纤维化的重组人脱氧核糖核酸酶
Cochrane Database Syst Rev. 2016 Apr 4;4:CD001127. doi: 10.1002/14651858.CD001127.pub3.
4
Azithromycin is the answer in paediatric respiratory medicine, but what was the question?阿奇霉素是儿科呼吸医学的答案,但问题是什么?
Paediatr Respir Rev. 2020 Apr;34:67-74. doi: 10.1016/j.prrv.2019.07.002. Epub 2019 Aug 16.
5
The use of pulmonary clearance medications in the acutely ill patient.肺部清除药物在急性病患者中的应用。
Expert Rev Respir Med. 2017 Oct;11(10):815-826. doi: 10.1080/17476348.2017.1358089. Epub 2017 Aug 18.
6
The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?用于辅助痰液清除的药物种类不断增加:应如何使用这些药物以优化治疗?
Curr Opin Pulm Med. 2014 Nov;20(6):601-6. doi: 10.1097/MCP.0000000000000104.
7
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
8
Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis.原发性纤毛运动障碍:基于囊性纤维化的经验探索新疗法的前景。
Paediatr Respir Rev. 2009 Jun;10(2):58-62. doi: 10.1016/j.prrv.2008.11.003. Epub 2009 Apr 9.
9
Other medications for aerosol delivery.其他用于雾化给药的药物。
Paediatr Respir Rev. 2006;7 Suppl 1:S76-9. doi: 10.1016/j.prrv.2006.04.183. Epub 2006 Jun 5.
10
Dornase in non-CF.非囊性纤维化患者使用的脱氧核糖核酸酶
Pediatr Pulmonol Suppl. 2004;26:154-5. doi: 10.1002/ppul.70090.

引用本文的文献

1
Effectiveness of mechanical vibration-assisted sputum clearance in pediatric pneumonia: a randomized controlled trial with development of an intelligent parameter optimization model.机械振动辅助排痰在小儿肺炎中的有效性:一项开发智能参数优化模型的随机对照试验
Front Pediatr. 2025 Jun 26;13:1539218. doi: 10.3389/fped.2025.1539218. eCollection 2025.
2
Patterns of Use of β-2 Agonists, Steroids, and Mucoactive Medications to Treat Bronchiolitis in the PICU: U.S. Pediatric Health Information System 2009-2022 Database Study.在儿科重症监护病房使用β-2激动剂、类固醇和黏液活性药物治疗细支气管炎的模式:美国儿科健康信息系统2009 - 2022数据库研究
Pediatr Crit Care Med. 2025 Mar 1;26(3):e294-e303. doi: 10.1097/PCC.0000000000003670. Epub 2024 Dec 17.
3

本文引用的文献

1
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4.
2
Reducing Albuterol Use in Children With Bronchiolitis.减少毛细支气管炎患儿沙丁胺醇的使用。
Pediatrics. 2020 Jan;145(1). doi: 10.1542/peds.2019-0306. Epub 2019 Dec 6.
3
Trends in Bronchiolitis Hospitalizations in the United States: 2000-2016.美国毛细支气管炎住院治疗趋势:2000-2016 年。
Severe respiratory syncytial virus disease.严重呼吸道合胞病毒疾病
J Intensive Med. 2024 Apr 20;4(4):405-416. doi: 10.1016/j.jointm.2024.03.001. eCollection 2024 Oct.
4
Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review.儿童和青少年支气管扩张症的治疗管理:简要叙述性综述
J Clin Med. 2024 Aug 13;13(16):4757. doi: 10.3390/jcm13164757.
5
Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective.儿童呼吸道疾病吸入性黏液活性药物专家小组建议:印度视角
Front Pediatr. 2023 Dec 4;11:1322360. doi: 10.3389/fped.2023.1322360. eCollection 2023.
6
Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV).呼吸道合胞病毒(RSV)的预防与治疗策略
Pathogens. 2023 Jan 17;12(2):154. doi: 10.3390/pathogens12020154.
7
Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases.基于纳米颗粒的肺部疾病吸入治疗。
Curr Drug Metab. 2022;23(11):882-896. doi: 10.2174/1389200223666220803103039.
8
Everything That Wheezes Is Not Asthma: A Case Report.并非所有哮鸣音都是哮喘:病例报告。
Pediatr Allergy Immunol Pulmonol. 2021 Sep;34(3):119-123. doi: 10.1089/ped.2021.0006. Epub 2021 Jun 18.
9
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey.α-糜蛋白酶在儿科重症监护病房的应用:现有文献与全国性横断面调查
Eur J Hosp Pharm. 2022 May;29(3):123-128. doi: 10.1136/ejhpharm-2020-002507. Epub 2020 Oct 29.
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2019-2614. Epub 2019 Nov 7.
4
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial.住院毛细支气管炎患者雾化吸入3%高渗盐水1天与3天的疗效比较:一项双盲非劣效性随机对照试验
BMC Pediatr. 2019 Nov 8;19(1):417. doi: 10.1186/s12887-019-1804-0.
5
Nebulised hypertonic saline in moderate-to-severe bronchiolitis: a randomised clinical trial.雾化高渗盐水治疗中重度细支气管炎的随机临床试验。
Arch Dis Child. 2020 Mar;105(3):236-240. doi: 10.1136/archdischild-2019-317160. Epub 2019 Sep 5.
6
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.吸入高渗盐水治疗囊性纤维化学龄前儿童(SHIP):一项多中心、随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2019 Sep;7(9):802-809. doi: 10.1016/S2213-2600(19)30187-0. Epub 2019 Jun 6.
7
Nebulised hypertonic saline in children with bronchiolitis admitted to the paediatric intensive care unit: A retrospective study.《儿科重症监护病房毛细支气管炎患儿雾化吸入高渗盐水:一项回顾性研究》
J Paediatr Child Health. 2019 Sep;55(9):1125-1132. doi: 10.1111/jpc.14371. Epub 2019 Jan 6.
8
Long-Term Effects of Saline Instilled During Endotracheal Suction in Pediatric Intensive Care: A Randomized Trial.经气管吸引时注入生理盐水对儿科重症监护患者的长期影响:一项随机试验。
Am J Crit Care. 2018 Nov;27(6):486-494. doi: 10.4037/ajcc2018615.
9
Hypertonic Saline in Bronchiolitis and Type I Error: A Trial Sequential Analysis.高渗盐水治疗细支气管炎和Ⅰ类错误:一项试验序贯分析。
Pediatrics. 2018 Sep;142(3). doi: 10.1542/peds.2018-1144. Epub 2018 Aug 16.
10
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.N-乙酰半胱氨酸作为一种抗氧化剂和二硫键断裂剂:原因如下。
Free Radic Res. 2018 Jul;52(7):751-762. doi: 10.1080/10715762.2018.1468564. Epub 2018 May 9.